Cargando…
Propranolol in the Treatment of Infantile Hemangiomas
Propranolol, as the first generation of β-blocker family, was initially introduced in the clinical application for tachycardia and hypertension in the 1960s. However, the occasional discovery of propranolol in the involution of infantile hemangiomas (IHs) brought us a new perspective. IHs are the mo...
Autores principales: | Tan, Xin, Guo, Shu, Wang, Chenchao |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8423716/ https://www.ncbi.nlm.nih.gov/pubmed/34511960 http://dx.doi.org/10.2147/CCID.S332625 |
Ejemplares similares
-
Propranolol for treatment of infantile hemangiomas
por: de Melo, Juliana Nakano, et al.
Publicado: (2013) -
Propranolol for Infantile Hemangiomas
por: Levy, Moise L.
Publicado: (2012) -
Mechanisms of propranolol action in infantile hemangioma
por: Kum, Jina JY, et al.
Publicado: (2015) -
Severe hypoglycemia in propranolol treatment for infantile hemangiomas
por: Morimoto, Akira, et al.
Publicado: (2022) -
Our experience with propranolol for infantile hemangioma
por: Wu, Yao, et al.
Publicado: (2023)